UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (574) 574
science & technology (534) 534
life sciences & biomedicine (529) 529
male (429) 429
female (420) 420
middle aged (343) 343
adult (315) 315
esomeprazole (272) 272
esomeprazole - administration & dosage (236) 236
esomeprazole - therapeutic use (236) 236
gastroenterology & hepatology (233) 233
aged (230) 230
pharmacology & pharmacy (227) 227
treatment outcome (219) 219
esomeprazole - adverse effects (213) 213
proton pump inhibitors (202) 202
gastroesophageal reflux - drug therapy (143) 143
proton pump inhibitors - adverse effects (134) 134
drug therapy, combination (132) 132
anti-ulcer agents - therapeutic use (122) 122
helicobacter infections - drug therapy (120) 120
proton pump inhibitors - therapeutic use (117) 117
anti-ulcer agents - administration & dosage (114) 114
helicobacter pylori (114) 114
double-blind method (113) 113
omeprazole (111) 111
proton pump inhibitors - administration & dosage (104) 104
adolescent (101) 101
prospective studies (98) 98
anti-ulcer agents - adverse effects (95) 95
young adult (93) 93
medicine & public health (84) 84
drug administration schedule (82) 82
gastroesophageal reflux (82) 82
dose-response relationship, drug (79) 79
aged, 80 and over (70) 70
internal medicine (69) 69
cross-over studies (68) 68
helicobacter pylori - drug effects (66) 66
care and treatment (63) 63
anti-bacterial agents - therapeutic use (62) 62
lansoprazole (62) 62
abridged index medicus (61) 61
pharmacology/toxicology (61) 61
drug therapy (59) 59
general & internal medicine (59) 59
proton pump inhibitor (59) 59
rabeprazole (59) 59
drug interactions (57) 57
omeprazole - adverse effects (57) 57
clinical trials (56) 56
administration, oral (55) 55
esomeprazole - pharmacology (55) 55
medicine, general & internal (55) 55
omeprazole - therapeutic use (55) 55
amoxicillin - therapeutic use (54) 54
risk factors (52) 52
time factors (51) 51
anti-bacterial agents - administration & dosage (50) 50
amoxicillin - administration & dosage (49) 49
hydrogen-ion concentration (49) 49
dosage and administration (47) 47
anti-bacterial agents - adverse effects (46) 46
health aspects (46) 46
esomeprazole - pharmacokinetics (45) 45
pantoprazole (44) 44
2-pyridinylmethylsulfinylbenzimidazoles (42) 42
amoxicillin (42) 42
pharmacokinetics (42) 42
pharmacotherapy (40) 40
analysis (38) 38
follow-up studies (35) 35
helicobacter infections - microbiology (35) 35
omeprazole - administration & dosage (35) 35
ulcers (35) 35
anti-inflammatory agents, non-steroidal - adverse effects (34) 34
clarithromycin - administration & dosage (34) 34
clarithromycin - therapeutic use (34) 34
gastroesophageal reflux disease (34) 34
research (34) 34
anti-ulcer agents - pharmacology (33) 33
breath tests (33) 33
gastric acid - secretion (33) 33
proton pump inhibitors - pharmacology (33) 33
severity of illness index (33) 33
animals (32) 32
gastroesophageal reflux - complications (32) 32
helicobacter infections (32) 32
medical research (31) 31
medicine, experimental (30) 30
peptic ulcer (30) 30
pharmacology (30) 30
gastroenterology (29) 29
2-pyridinylmethylsulfinylbenzimidazoles - administration & dosage (28) 28
anti-ulcer agents - pharmacokinetics (28) 28
enzyme inhibitors - therapeutic use (28) 28
levofloxacin (28) 28
enzyme inhibitors - adverse effects (27) 27
esophagitis, peptic - drug therapy (27) 27
gastric acidity determination (27) 27
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (635) 635
French (10) 10
German (6) 6
Spanish (6) 6
Chinese (3) 3
Japanese (3) 3
Russian (3) 3
Dutch (2) 2
Portuguese (2) 2
Bulgarian (1) 1
Norwegian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA : the journal of the American Medical Association, ISSN 0098-7484, 05/2011, Volume 305, Issue 19, pp. 1969 - 1977
Journal Article
The Lancet (British edition), ISSN 0140-6736, 06/2017, Volume 389, Issue 10087, pp. 2375 - 2382
Summary Background Present guidelines are conflicting for patients at high risk of both cardiovascular and gastrointestinal events who continue to require... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Celecoxib - administration & dosage | Recurrence | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Secondary Prevention - methods | Aspirin - administration & dosage | Cyclooxygenase 2 Inhibitors - adverse effects | Proton Pump Inhibitors - administration & dosage | Aspirin - adverse effects | Naproxen - administration & dosage | Cyclooxygenase 2 Inhibitors - therapeutic use | Peptic Ulcer Hemorrhage - prevention & control | Aged, 80 and over | Aspirin - therapeutic use | Drug Therapy, Combination | Celecoxib - adverse effects | Naproxen - adverse effects | Proton Pump Inhibitors - adverse effects | Double-Blind Method | Drug Administration Schedule | Cyclooxygenase 2 Inhibitors - administration & dosage | Peptic Ulcer Hemorrhage - chemically induced | Celecoxib - therapeutic use | Proton Pump Inhibitors - therapeutic use | Naproxen - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Arthritis - drug therapy | Aged | Care and treatment | Aspirin | Anti-inflammatory drugs | Gastrointestinal diseases | Naproxen | Clinical trials | Arthritis | Complications and side effects | Medical research | Gastrointestinal bleeding | Medicine, Experimental | Drugs | Funding | Risk | Population studies | Hemorrhage | Evidence-based medicine | Bleeding | Incidence | Motivation | Safety | Nonsteroidal anti-inflammatory drugs | Digestive system | Risk reduction | Inflammation | Celecoxib | Patients | Anti-inflammatory agents | Diseases | Omeprazole | Random numbers | Inhibitors | Ulcers | Healing | Fatalities | Cyclooxygenase-2 | Cardiovascular diseases | Health risk assessment | Protons | Randomization | Analgesics | Endoscopy | Drug dosages | Mortality | Health risks | Hospitals | Index Medicus | Abridged Index Medicus
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 08/2013, Volume 128, Issue 8, pp. 845 - 853
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2007, Volume 369, Issue 9573, pp. 1621 - 1626
Journal Article
Alimentary pharmacology & therapeutics, ISSN 0269-2813, 03/2015, Volume 41, Issue 6, pp. 581 - 589
Journal Article